Tag: Third generation cephalosporin

Cefixime is classified as a third-generation cephalosporin antibiotic, first approved for medical use in the United States in 1989. This broad-spectrum medication is an important treatment for various bacterial infections, and understanding its specific classification is key to understanding its clinical applications.

As third-generation cephalosporin antibiotics, both cefotaxime and ceftazidime are crucial for treating serious bacterial infections, but their distinct antibacterial profiles mean they are not interchangeable. This guide explores the fundamental differences between cefotaxime and ceftazidime, detailing their specific strengths and clinical uses.

In the United States, *Pseudomonas aeruginosa* is estimated to cause 32,600 infections in hospitalized patients annually [1.7.4]. This article addresses the critical question: Does ceftriaxone cover *Pseudomonas*?